
DermaSensor
AI-powered handheld device for early skin cancer detection, aiding dermatologists.
About
DermaSensor has developed a handheld, AI-powered device designed to assist dermatologists in the early detection of skin cancer. The device uses advanced imaging and artificial intelligence to analyze skin lesions, providing dermatologists with objective data to support their diagnostic decisions and improve patient outcomes.
Key facts
At-a-glance profile data
- Website
- dermasensor.com
- Headquarters
- Miami, United States
- Total funding
- $15M (Series A)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 21 Sept 2021 | Series A | $15M | Catalyst Health Ventures |
Tech stack
Detected on dermasensor.com, last scanned 24 Sept 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Tag Manager
- SEO
- Yoast SEO
- Support
- HubSpot
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Google Workspace
- Maps
- Google Maps
Frequently asked
How much funding has DermaSensor raised?
DermaSensor has raised a total of $15M in funding. The most recent round on record is Series A.